Industry News

Emerging Biopharma’s Contribution to Innovation

The majority of biomedical innovation is developed by emerging biopharma (EBP) companies, many of which have never marketed a therapy before. Over time, those companies either successfully bring their products to market or, in many cases, their assets or whole companies are acquired by others. These EBP companies are at…

HR, Partner and Collaborator News

New York health system names inaugural chief strategy and transformation officer

Liz Popwell was named chief strategy and transformation officer of Stony Brook (N.Y.) Medicine. Ms. Popwell will start the newly created position on July 7, with responsibilities including strategic planning and implementation, transformation and business development, according to a news release shared with Becker’s. Prior to this new role, she served…

Fundraising/IPO, Partner and Collaborator News

Rutgers Faculty Receives PCORI Contract to Develop Robust Longitudinal Causal Inference Methods with Machine Learning

Newswise — Rutgers School of Public Health associate professor, Liangyuan Hu, has received a three-year $1,069,876 Patient-Centered Outcomes Research Institute (PCORI) contract. Hu will use the funding award to develop robust and flexible causal inference methods and tools, leveraging machine learning, for longitudinal treatments. The developed methods will be used to…

Collaborations, Competitor News, Data Partnership, Oncology, Pharma

Tempus Announces Sequencing Collaboration With Lilly to Expand Access to Genomic Testing

June 09, 2022 10:00 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced a new collaboration sponsored by Eli Lilly and Company designed to provide broader access to genomic testing to patients with advanced/metastatic non-small cell lung cancer (NSCLC). Leveraging Tempus tests, this…

Competitor News, Product Updates

Hot off its Cerner acquisition, Oracle is developing a national health records database

Two days after it completed its $28.4 billion acquisition of Cerner, Oracle announced plans to build a national, anonymized health information management system. By KATIE ADAMS Post a comment / Jun 9, 2022 at 7:31 PM Oracle completed its $28.4 billion acquisition of Cerner on Tuesday, prompting many to wonder what healthcare plans the…

AI, Ethics, Industry News

Responsible AI Institute Expands in the UK and EU to Advance AI Certification Efforts

LONDON, June 08, 2022 (GLOBE NEWSWIRE) — Responsible AI Institute (RAII), the leading non-profit dedicated to independent AI assessments and certification, today announced the expansion of its operations in the UK and Europe to further harmonize its AI certification efforts with industry-leading AI regulations and in the US and Canada and expand…

Competitor News, Government/Regulatory, Oncology

U.S. FDA approves Foundation Medicine’s FoundationOne®CDx as a companion diagnostic for Roche’s Rozlytrek® (entrectinib)

June 09, 2022 01:03 ET | Source: F. Hoffmann-La Roche Ltd FoundationOne CDx can now be used to identify patients with ROS1 fusion-positive non-small cell lung cancer or patients with NTRK fusion-positive solid tumours for whom treatment with Rozlytrek may be appropriate This approval marks the first and only companion diagnostic indication for Rozlytrek, and another important milestone in tumour-agnostic…